using glp 1 GLP-1 Medications for Weight Loss: What You Should Know T1Ds Using GLP-1s: Latest Research

As of mid-2025, over 1,800 Ozempic vision loss lawsuits have been filed alleging the pharmaceutical company failed to warn patients and doctors about the risk of permanent blindness, despite mounting scientific evidence linking semaglutide to optic nerve damage

DSIP in the Treatment of Withdrawal Syndromes from Alcohol and Opiates

Summary: Sulphur burps and diarrhoea are common gastrointestinal side effects of retatrutide, caused primarily by slowed gastric emptying and altered gut motility resulting from its triple receptor agonist activity

S.ArabiB.BrockmuellerA.ShakibaeiM.BsselbergD

Patients are randomized to pemvidutide 1.2 or 1.8 mg weekly, or placebo for 24 weeks, with primary endpoints of MASH resolution without fibrosis progression and fibrosis amelioration without MASH deterioration